1-甲基-3-苯基丙胺 | 937-52-0

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1-甲基-3-苯基丙胺
• 中文别名: (R)-(-)-1-甲基-3-苯基丙胺；(R)-(-)-1-甲基-3-苯基丙胺1-甲基-3-苯基丙胺
• 英文名称: (R)-1-methyl-3-phenylpropylamine
• 英文别名: (R)-4-phenylbutan-2-amine；(R)-4-phenyl-2-butylamine；4-phenylbutan-2-amine；(R)-α-methylbenzenepropanamine；(R)-2-amino-4-phenylbutane；1-methyl-3-phenylpropylamine；(R)-(-)-1-Methyl-3-phenylpropylamine；(2R)-4-phenylbutan-2-amine
• CAS: 937-52-0
• 化学式: C₁₀H₁₅N
• 分子量: 149.236
• InChiKey: WECUIGDEWBNQJJ-SECBINFHSA-N

物化性质

• 熔点：
  143°C (estimate)
• 比旋光度：
  -11 º (neat)
• 沸点：
  230.33°C (estimate)
• 密度：
  0.936
• 稳定性/保质期：
  在常温常压下保持稳定，应避免与强氧化剂接触。

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2921499090
• 储存条件：
  密封储存于阴凉干燥处，建议冷藏温度保持在4°C。

SDS

Name:	(R)-(-)-1-Methyl-3-Phenylpropylamine Material Safety Data Sheet
Synonym:	None known
CAS:	937-52-0

Section 1 - Chemical Product MSDS Name:(R)-(-)-1-Methyl-3-Phenylpropylamine Material Safety Data Sheet
Synonym:None known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
937-52-0	(R)-(-)-1-Methyl-3-Phenylpropylamine	ca 100	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.)

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 937-52-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H15N
Molecular Weight: 149.24

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 937-52-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(R)-(-)-1-Methyl-3-Phenylpropylamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 37/39 Wear suitable gloves and eye/face
protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 937-52-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 937-52-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 937-52-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-甲基-3-苯基丙胺 在 sodium azide 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 13.25h， 生成 (S)-1-甲基-3-苯基丙基叠氮化物
  参考文献：
  名称：

  胺通过手性2,4,6-三苯基吡啶鎓中间体的立体选择性转化

  摘要：

  我们在此报告了手性2,4,6-三苯基吡啶鎓四氟硼酸酯2a和2b的制备和亲核取代。三苯基吡啶中间体是由高手性胺（1a，1b）和2,4,6-三苯基吡啶四氟硼酸酯生成的，并用作立体选择性亲核取代的底物。已经研究了取代反应中的转化度。获得的醇（3a，3b）和叠氮化物（4a，4b）产物的构型转化率分别大于99％和96–98％。

  DOI：

  10.1016/s0957-4166(01)00343-3
• 作为产物：
  描述：

  (2R,1'R)-[1'-(1-naphthyl)ethyl]-4-phenyl-2-butylamine 在 palladium dihydroxide 氢气 作用下， 以 甲醇 为溶剂， 反应 8.0h， 生成 1-甲基-3-苯基丙胺
  参考文献：
  名称：

  烷基锂与手性亚胺的不对称加成：α-萘乙基为手性助剂。

  摘要：

  进行烷基锂到N-亚烷基-α-萘乙胺的非对映选择性亲核加成。在路易斯酸或路易斯碱的存在下，有机锂与亚胺平稳反应，以高立体选择性（最高100％de）生成相应的胺。此外，发现所得的光学活性胺作为手性配体可用于不对称反应。

  DOI：

  10.1021/jo9908602

文献信息

• Organocerium additions to proline-derived hydrazones: synthesis of enantiomerically enriched amines
  作者：Scott E. Denmark、James P. Edwards、Theodor Weber、David W. Piotrowski

  DOI：10.1016/j.tetasy.2010.04.042

  日期：2010.5

  The addition of organocerium reagents (from both organolithium and organomagnesium precursors) to chiral aldehyde hydrazones prepared from 1-aminoproline derivatives has been studied. The additions proceed in good yield and high diastereoselectivity and with good nucleophile (Me, n-Bu, i-Pr, t-Bu, Ph, etc.) and substrate scope (alkyl, alkenyl and aryl). The resulting hydrazines can be converted to

  已经研究了将有机铈试剂（来自有机锂和有机镁前体）添加到由1-氨基脯氨酸衍生物制备的手性醛中。添加以高收率和高非对映选择性以及良好的亲核试剂（Me，n- Bu，i- Pr，t- Bu，Ph等）和底物范围（烷基，烯基和芳基）进行。生成的肼可通过氢解（阮内镍）的N–N键裂解或通过Li / NH 3的酰化和裂解而转化为胺。。通过改变取代基以包括更多的配位原子（氧和氮）以及去除配位原子，研究了侧链对非对映选择性的影响。带有2-甲氧基乙氧基甲基的SAMEMP助剂具有最高的非对映选择性。值得注意的是，带有简单甲基和异丁基取代基的助剂也具有很高的选择性。给出了选择性起源的假设。
• One-Pot Transformation of Ketoximes into Optically Active Alcohols and Amines by Sequential Action of Laccases and Ketoreductases or ω-Transaminases
  作者：Raquel S. Correia Cordeiro、Nicolás Ríos-Lombardía、Francisco Morís、Robert Kourist、Javier González-Sabín

  DOI：10.1002/cctc.201801900

  日期：2019.2.20

  An enzymatic one‐pot process for asymmetric transformation of prochiral ketoximes into alcohols or amines was developed by sequential coupling of a laccase‐catalyzed deoximation either with a ketone reduction (ketoreductase, KRED) or bioamination (ω‐transaminase, ω‐TA) in aqueous medium. An accurate selection of biocatalysts provided the corresponding products in excellent enantiomeric excesses and

  通过将漆酶催化的脱肟与酮还原（酮还原酶，KRED）或生物胺化（ω-转氨酶，ω-TA）相继偶联，开发了一种酶法一锅法，用于将前手性酮肟不对称转化为醇或胺。中等的。正确选择生物催化剂后，相应的产品的对映体过量非常好，醇的总转化率从83％到> 99％，胺的总转化率从70％到> 99％。同样，仅使用1％（w / w）的Cremophor®（一种聚乙氧基化蓖麻油）作为助溶剂，可使手性醇级联反应中的浓度达到100 mM。
• Arylethanolamines derived from salicylamide with .alpha.- and .beta.-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers and related salicylamides
  作者：James E. Clifton、Ian Collins、Peter Hallett、David Hartley、Lawrence H. C. Lunts、Philip D. Wicks

  DOI：10.1021/jm00348a013

  日期：1982.6

  A series of phenethanolamines (3) based on salicylamide has been prepared and shown to possess beta-adrenergic blocking properties. When the basic nitrogen atom was substituted by some aralkyl groups, the compounds also blocked alpha-adrenoceptors. The 1-methyl-3-phenylpropyl derivative labetalol (34) is antihypertensive in animals and man, and syntheses of its four stereoisomers are described. The

  已经制备了一系列基于水杨酰胺的苯乙醇胺（3），并显示出具有β-肾上腺素阻断特性。当碱性氮原子被某些芳烷基取代时，这些化合物也会封闭α-肾上腺素受体。1-甲基-3-苯基丙基衍生物拉贝洛尔（34）在动物和人类中均具有降压作用，并描述了其四种立体异构体的合成。在两个不对称中心具有R构型的对映体90具有大部分的β-阻断活性，但是几乎没有α-阻断活性。在醇碳上具有S构型并且在氨基取代基上具有R构型的化合物主要是α-肾上腺素受体阻断剂89。
• [EN] SYNTHESIS OF AMINE STEREOISOMERS<br/>[FR] SYNTHESE DE STEREOISOMERES D'AMINES
  申请人：INTERNAT UNIVERSITY BREMEN GMB

  公开号：WO2006030017A1

  公开（公告）日：2006-03-23

  The invention relates to methods for producing secondary and tertiary amine diastereomers and corresponding enantiopure or enantioenriched primary or secondary chiral amine products.

  这项发明涉及生产二级和三级胺对映异构体以及相应的对映纯或对映富集的一级或二级手性胺产品的方法。
• Connecting Unexplored Protein Crystal Structures to Enzymatic Function
  作者：Fabian Steffen-Munsberg、Clare Vickers、Ahmad Thontowi、Sebastian Schätzle、Tony Tumlirsch、Maria Svedendahl Humble、Henrik Land、Per Berglund、Uwe T. Bornscheuer、Matthias Höhne

  DOI：10.1002/cctc.201200544

  日期：2013.1

  Digging in the database: Four synthetically useful transaminases for which no function was known were studied by evaluating a set of eight amino donors and seven acceptors (see figure). The four enzymes differ substantially in their catalytic properties and substrate preferences. We also used the enzymes in the asymmetric synthesis of a range of chiral amines and observed excellent enantioselectivities

  在数据库中进行挖掘：通过评估一组八个氨基供体和七个受体，研究了四个未知功能的合成有用的转氨酶（见图）。四种酶的催化特性和底物偏好存在很大差异。我们还在一系列手性胺的不对称合成中使用了这些酶，并观察到出色的对映选择性和转化率。